Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization
- 1 May 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 35 (5), 1296-1301
- https://doi.org/10.1097/01.ccm.0000262403.08546.a2
Abstract
To assess the health economic impact of perioperative myocardial infarction in a cohort of patients undergoing coronary artery bypass graft surgery. Retrospective cohort analysis using data from hospital bills and uniform billing forms. A total of 147 geographically diverse hospitals in the United States. The study population consisted of 2,102 coronary artery bypass graft surgery patients enrolled in the PRIMO-CABG trial at U.S. sites between January 2002 and February 2003. None. Resource utilization and costs during the index hospitalization and during a 6-month follow-up period were compared between patients who had a myocardial infarction by postoperative day 4 and those who did not. Linear regression was used to examine whether myocardial infarction by day 4 was associated with index hospitalization costs, after adjusting for baseline characteristics. Myocardial infarction occurred in 191 (9.1%) patients undergoing coronary artery bypass graft surgery. Myocardial infarction was associated with a doubling of intensive care unit time (3.5 days among patients with no myocardial infarction and 7.1 days among patients with myocardial infarction, p Conclusions: Myocardial infarction following coronary artery bypass graft surgery was associated with a significant increase in intensive care unit time, hospital length of stay, and overall costs, which contributed to greater hospital and physician service costs. Healthcare resource utilization is increased in patients sustaining a myocardial infarction following coronary artery bypass graft surgery.Keywords
This publication has 19 references indexed in Scilit:
- Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical PatientsThe Annals of Thoracic Surgery, 2006
- Terminal Complement Blockade With Pexelizumab During Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary BypassJama-Journal Of The American Medical Association, 2004
- Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life OutcomesJama-Journal Of The American Medical Association, 2004
- Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trialThe Lancet, 2002
- A decade of change—risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research InstituteThe Annals of Thoracic Surgery, 2002
- Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass SurgeryNew England Journal of Medicine, 2001
- Costs of revascularization over eight years in the randomized and eligible patients in the emory angioplasty versus surgery trial (EAST)The American Journal of Cardiology, 2000
- Variability in Transfusion Practice for Coronary Artery Bypass Surgery Persists Despite National Consensus Guidelines Anesthesiology, 1998
- Atrial Fibrillation Following Coronary Artery Bypass Graft SurgeryJama-Journal Of The American Medical Association, 1996
- Results and Policy Implications of the Resource-Based Relative-Value StudyNew England Journal of Medicine, 1988